why choose us

First received: November 16, 2022

Clinical Trial: BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome

Study Status: Completed

Recruit Status: RECRUITING

Condition: Acute Myeloid Leukemia

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Study of BXCL701 in Relapsed/Refractory Acute Myeloid Leukemia or Relapsed/Refractory Myelodysplastic Syndrome With Excess Blasts - 2

Brief Summary: The goal of this research study is to find the safest and most effective dose of the study drug, BXCL701, for the treatment of Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS).The names of the study drugs involved in this study are/is:BXCL701

Read more